Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy

Monica Galli*, Manik Chatterjee, Mariella Grasso, Giorgina Specchia, Hila Magen, Hermann Einsele, Ivana Celeghini, Paola Barbieri, David Paoletti, Silvia Pace, Ralph D. Sanderson, Alessandro Rambaldi, Arnon Nagler

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e469-e472
JournalHaematologica
Volume103
Issue number10
DOIs
StatePublished - 30 Sep 2018
Externally publishedYes

Funding

FundersFunder number
National Cancer InstituteR01CA211752

    Cite this